Kynam Capital Management, LP
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 1907884
PRINCETON, NJ
Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$175,993,963
-$12,076,439 QoQ
Shares Held
8,050,959
0.0% QoQ
Ownership
9.02%
of shares outstanding
% of Portfolio
9.73%
of 13F equity value
Holder Rank
#2
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Derivatives in SNDX
reported options exposure · as of Sep 30, 2023CallValue
$5,808,000
CallShares
400,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kynam Capital Management, LP holds $1,765,169,848 across 29 Biotechnology names. SNDX ranks #2 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CLDX |
Celldex Therapeutics, Inc.
|
5,322,908 | $198,065,406 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
This page
|
8,050,959 | $175,993,963 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,922,335 | $169,875,333 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
3,667,097 | $141,916,653 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
2,890,059 | $124,012,431 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,453,877 | $118,557,720 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,000,000 | $113,620,000 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
2,840,792 | $97,495,981 |
All Filings in SNDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,993,963 | 8,050,959 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $188,070,402 | 8,050,959 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $169,150,648 | 8,050,959 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $131,080,200 | 8,520,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $79,789,800 | 8,520,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $104,668,200 | 8,520,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $112,634,400 | 8,520,000 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $112,634,400 | 8,520,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $112,476,306 | 5,842,925 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $117,473,830 | 5,722,057 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $134,708,000 | 5,660,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $122,312,600 | 5,660,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,808,000 | 400,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $52,272,000 | 3,600,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $68,273,743 | 3,262,004 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $67,710,424 | 3,205,986 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $65,182,209 | 2,561,187 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $54,618,147 | 2,272,915 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $48,335,497 | 2,512,240 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $33,592,064 | 1,932,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $20,930,451 | 956,165 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||